Search - tctmd.com

Displaying 961 - 980 of 1189

Sort: Relevancy | Date

Grapefruit Juice Prolongs QT Interval, but How Much Does It Matter?

News Conference News HRS 2019

Grapefruit Juice Prolongs QT Interval, but How Much Does It Matter?

May 13, 2019

ERADICATE-AF: Could Add-on Renal Denervation Give A-fib Ablation a Boost?

News Conference News HRS 2019

ERADICATE-AF: Could Add-on Renal Denervation Give A-fib Ablation a Boost?

May 10, 2019

Warning Signs: Many Cardiac-Arrest Victims Visited Doctors, Emergency Rooms Prior to Events

News Daily News

Warning Signs: Many Cardiac-Arrest Victims Visited Doctors, Emergency Rooms Prior to Events

Yael L. Maxwell

May 10, 2019

Staged, Complete PCI Beats Culprit Stenting Out to 5 Years in STEMI Patients

News Daily News

Staged, Complete PCI Beats Culprit Stenting Out to 5 Years in STEMI Patients

May 10, 2019

HRS Urges Members to Get Aboard the Digital Health Train

News Conference News HRS 2019

HRS Urges Members to Get Aboard the Digital Health Train

May 10, 2019

Vagus Nerve Stimulation Lightens Arrhythmia Burden in Patients With Paroxysmal A-fib

News Conference News HRS 2019

Vagus Nerve Stimulation Lightens Arrhythmia Burden in Patients With Paroxysmal A-fib

May 09, 2019

Patients Often Lack Basic Knowledge About Their Implanted Devices

News Conference News HRS 2019

Patients Often Lack Basic Knowledge About Their Implanted Devices

May 08, 2019

FDA Tallies Cases of Fournier Gangrene in Patients Taking SGLT2 Inhibitors

News Daily News

FDA Tallies Cases of Fournier Gangrene in Patients Taking SGLT2 Inhibitors

Michael O'Riordan

May 08, 2019

Vici Venous Stent Receives FDA Approval for Iliofemoral Obstructive Disease

News Daily News

Vici Venous Stent Receives FDA Approval for Iliofemoral Obstructive Disease

May 06, 2019

Elevations in hs-cTnI Linked to Higher Risk of CVD, Particularly Heart Failure

News Daily News

Elevations in hs-cTnI Linked to Higher Risk of CVD, Particularly Heart Failure

Michael O'Riordan

May 06, 2019

Tafamidis Approved for Treatment of Transthyretin Amyloid Cardiomyopathy

News Daily News

Tafamidis Approved for Treatment of Transthyretin Amyloid Cardiomyopathy

Michael O'Riordan

May 06, 2019

Mortality From Heart Failure Increasing in United States

News Daily News

Mortality From Heart Failure Increasing in United States

Michael O'Riordan

May 06, 2019

CABANA Results Largely Generalizable to Real-World A-fib Patients

News Daily News

CABANA Results Largely Generalizable to Real-World A-fib Patients

May 03, 2019

Peripheral Vision: As Office-Based Practices Proliferate, Who Is Watching Out for Patients?

News Features

Peripheral Vision: As Office-Based Practices Proliferate, Who Is Watching Out for Patients?

May 01, 2019

TCTMD’s Top 10 Most Popular Stories for April 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for April 2019

May 01, 2019

Twitter Takes on the Times of India, but the Question Persists: Is Foregoing a Stent an Option?

News Features

Twitter Takes on the Times of India, but the Question Persists: Is Foregoing a Stent an Option?

April 30, 2019

Experts Call on Training Programs to Incorporate Cardio-Oncology to Meet Growing Need

News Daily News

Experts Call on Training Programs to Incorporate Cardio-Oncology to Meet Growing Need

April 30, 2019

Three Years On, Absorb BVS Still Doesn’t Improve Myocardial Blood Flow

News Daily News

Three Years On, Absorb BVS Still Doesn’t Improve Myocardial Blood Flow

Michael O'Riordan

April 30, 2019

Analysis Supports Aiming for Lower BP in Patients With Diabetes, Hypertension

News Daily News

Analysis Supports Aiming for Lower BP in Patients With Diabetes, Hypertension

April 29, 2019

Patients Retain Little From Cath Lab Informed-Consent Conversations

News Daily News

Patients Retain Little From Cath Lab Informed-Consent Conversations

Michael O'Riordan

April 26, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.